86 related articles for article (PubMed ID: 28002775)
1. Novel inhibitors of Plasmodium falciparum based on 2,5-disubstituted furans.
Krake SH; Martinez PDG; McLaren J; Ryan E; Chen G; White K; Charman SA; Campbell S; Willis P; Dias LC
Eur J Med Chem; 2017 Jan; 126():929-936. PubMed ID: 28002775
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological characterisation and structure activity relationships of aromatic bisamidines active against Plasmodium falciparum.
Sauer B; Skinner-Adams TS; Bouchut A; Chua MJ; Pierrot C; Erdmann F; Robaa D; Schmidt M; Khalife J; Andrews KT; Sippl W
Eur J Med Chem; 2017 Feb; 127():22-40. PubMed ID: 28038325
[TBL] [Abstract][Full Text] [Related]
3. Antimalarial agents against both sexual and asexual parasites stages: structure-activity relationships and biological studies of the Malaria Box compound 1-[5-(4-bromo-2-chlorophenyl)furan-2-yl]-N-[(piperidin-4-yl)methyl]methanamine (MMV019918) and analogues.
Vallone A; D'Alessandro S; Brogi S; Brindisi M; Chemi G; Alfano G; Lamponi S; Lee SG; Jez JM; Koolen KJM; Dechering KJ; Saponara S; Fusi F; Gorelli B; Taramelli D; Parapini S; Caldelari R; Campiani G; Gemma S; Butini S
Eur J Med Chem; 2018 Apr; 150():698-718. PubMed ID: 29571157
[TBL] [Abstract][Full Text] [Related]
4. Expeditious synthesis and biological evaluation of novel 2,N6-disubstituted 1,2-dihydro-1,3,5-triazine-4,6-diamines as potential antimalarials.
Gravestock D; Rousseau AL; Lourens AC; Moleele SS; van Zyl RL; Steenkamp PA
Eur J Med Chem; 2011 Jun; 46(6):2022-30. PubMed ID: 21420762
[TBL] [Abstract][Full Text] [Related]
5. Medicinal chemistry optimization of antiplasmodial imidazopyridazine hits from high throughput screening of a SoftFocus kinase library: part 1.
Le Manach C; Gonzàlez Cabrera D; Douelle F; Nchinda AT; Younis Y; Taylor D; Wiesner L; White KL; Ryan E; March C; Duffy S; Avery VM; Waterson D; Witty MJ; Wittlin S; Charman SA; Street LJ; Chibale K
J Med Chem; 2014 Mar; 57(6):2789-98. PubMed ID: 24568587
[TBL] [Abstract][Full Text] [Related]
6. 2,3,8-Trisubstituted Quinolines with Antimalarial Activity.
Martinez PDG; Krake SH; Poggi ML; Campbell SF; Willis PA; Dias LC
An Acad Bras Cienc; 2018; 90(1 Suppl 2):1215-1231. PubMed ID: 29791525
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity-relationship studies around the 2-amino group and pyridine core of antimalarial 3,5-diarylaminopyridines lead to a novel series of pyrazine analogues with oral in vivo activity.
Younis Y; Douelle F; González Cabrera D; Le Manach C; Nchinda AT; Paquet T; Street LJ; White KL; Zabiulla KM; Joseph JT; Bashyam S; Waterson D; Witty MJ; Wittlin S; Charman SA; Chibale K
J Med Chem; 2013 Nov; 56(21):8860-71. PubMed ID: 24099149
[TBL] [Abstract][Full Text] [Related]
8. 3,5-bis(benzylidene)-4-piperidones and related N-acyl analogs: a novel cluster of antimalarials targeting the liver stage of Plasmodium falciparum.
Das U; Singh RS; Alcorn J; Hickman MR; Sciotti RJ; Leed SE; Lee PJ; Roncal N; Dimmock JR
Bioorg Med Chem; 2013 Dec; 21(23):7250-6. PubMed ID: 24139941
[TBL] [Abstract][Full Text] [Related]
9. Investigation into novel thiophene- and furan-based 4-amino-7-chloroquinolines afforded antimalarials that cure mice.
Opsenica IM; Verbić TŽ; Tot M; Sciotti RJ; Pybus BS; Djurković-Djaković O; Slavić K; Šolaja BA
Bioorg Med Chem; 2015 May; 23(9):2176-86. PubMed ID: 25801154
[TBL] [Abstract][Full Text] [Related]
10. Non-symmetrical furan-amidines as novel leads for the treatment of cancer and malaria.
Alnabulsi S; Santina E; Russo I; Hussein B; Kadirvel M; Chadwick A; Bichenkova EV; Bryce RA; Nolan K; Demonacos C; Stratford IJ; Freeman S
Eur J Med Chem; 2016 Mar; 111():33-45. PubMed ID: 26854376
[TBL] [Abstract][Full Text] [Related]
11. Discovery of 6'-chloro-N-methyl-5'-(phenylsulfonamido)-[3,3'-bipyridine]-5-carboxamide (CHMFL-PI4K-127) as a novel Plasmodium falciparum PI(4)K inhibitor with potent antimalarial activity against both blood and liver stages of Plasmodium.
Liang X; Jiang Z; Huang Z; Li F; Chen C; Hu C; Wang W; Hu Z; Liu Q; Wang B; Wang L; Qi Z; Liu J; Jiang L; Liu Q
Eur J Med Chem; 2020 Feb; 188():112012. PubMed ID: 31911293
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Marinoquinolines as Potent and Fast-Acting Plasmodium falciparum Inhibitors with in Vivo Activity.
Aguiar ACC; Panciera M; Simão Dos Santos EF; Singh MK; Garcia ML; de Souza GE; Nakabashi M; Costa JL; Garcia CRS; Oliva G; Correia CRD; Guido RVC
J Med Chem; 2018 Jul; 61(13):5547-5568. PubMed ID: 29879353
[TBL] [Abstract][Full Text] [Related]
13. 2-Oxotetrahydroquinoline-based antimalarials with high potency and metabolic stability.
Bulbule VJ; Rivas K; Verlinde CL; Van Voorhis WC; Gelb MH
J Med Chem; 2008 Feb; 51(3):384-7. PubMed ID: 18198825
[TBL] [Abstract][Full Text] [Related]
14. In vitro efficacy of 2,N-bisarylated 2-ethoxyacetamides against Plasmodium falciparum.
Gutteridge CE; Major JW; Nin DA; Curtis SM; Bhattacharjee AK; Gerena L; Nichols DA
Bioorg Med Chem Lett; 2016 Feb; 26(3):1048-1051. PubMed ID: 26750257
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro evaluation of novel 8-aminoquinoline-pyrazolopyrimidine hybrids as potent antimalarial agents.
Kannan M; Raichurkar AV; Khan FR; Iyer PS
Bioorg Med Chem Lett; 2015 Mar; 25(5):1100-3. PubMed ID: 25650255
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.
Kelly JX; Smilkstein MJ; Cooper RA; Lane KD; Johnson RA; Janowsky A; Dodean RA; Hinrichs DJ; Winter R; Riscoe M
Antimicrob Agents Chemother; 2007 Nov; 51(11):4133-40. PubMed ID: 17846138
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro evaluation of hydrazinyl phthalazines against malaria parasite, Plasmodium falciparum.
Subramanian G; Babu Rajeev CP; Mohan CD; Sinha A; Chu TTT; Anusha S; Ximei H; Fuchs JE; Bender A; Rangappa KS; Chandramohanadas R; Basappa
Bioorg Med Chem Lett; 2016 Jul; 26(14):3300-3306. PubMed ID: 27261180
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationships of 4-pyridones as potential antimalarials.
Yeates CL; Batchelor JF; Capon EC; Cheesman NJ; Fry M; Hudson AT; Pudney M; Trimming H; Woolven J; Bueno JM; Chicharro J; Fernández E; Fiandor JM; Gargallo-Viola D; Gómez de las Heras F; Herreros E; León ML
J Med Chem; 2008 May; 51(9):2845-52. PubMed ID: 18396855
[TBL] [Abstract][Full Text] [Related]
19. Development of antitrypanosomal and antiplasmodial nonpeptidic cysteine protease inhibitors based on N-protected-guanidino-furan and -pyrrole building blocks.
Langolf S; Machon U; Ehlers M; Sicking W; Schirmeister T; Büchhold C; Gelhaus C; Rosenthal PJ; Schmuck C
ChemMedChem; 2011 Sep; 6(9):1581-6. PubMed ID: 21678556
[No Abstract] [Full Text] [Related]
20. New derivatives of quinoline-4-carboxylic acid with antiplasmodial activity.
Hochegger P; Faist J; Seebacher W; Saf R; Mäser P; Kaiser M; Weis R
Bioorg Med Chem; 2017 Apr; 25(7):2251-2259. PubMed ID: 28279559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
